Issuance of key TMT Patent and Introduction of 18plex TMTpro Services
Proteome Sciences is pleased to announce the issuance to it of U.S. Patent No. 10,976,321 relating to methods of analysis using isobaric mass tags.
Change of registered office
The directors of Proteome Sciences announce that the Company’s registered office address has changed to 5 Dashwood Lang Road, Bourne Business Park, Addlestone, Surrey, KT15 2HJ with immediate effect.
Director/PDMR Shareholding
The Company has received notification from Roger McDowell, a Director of the Company, that on 16 April 2021 he purchased 900,000 Ordinary Shares in the Company at a price of 5.00p per share.
Director/PDMR Shareholding
The Company has received notification from Richard Dennis, Chief Commercial Officer, that on 12 April and 13 April 2021 he purchased, in aggregate, 625,000 Ordinary Shares in the Company at an average price of 5.22p per share. Richard Dennis now holds 625,000 Ordinary Shares in the Company, which represents approximately 0.21% of the issued share capital of the Company.
Annual Report and Financial Statements 31 December 2020
The Annual Report and Financial Statements for the year ended 31 December 2020, together with a notice of the Annual General Meeting is available to view on the Companies website www.proteomics.com and will be posted to shareholders imminently.
Holding(s) in Company
Holding(s) in Company - TR-1 notification was received from Helium Special Situations Fund on the 31 March 2021.
Investor Presentation
Proteome Sciences PLC is pleased to announce that Chief Executive Officer, Dr Mariola Soehngen, will provide a live presentation relating to the Company’s results for the year ended 31 December 2020 via the Investor Meet Company platform on Thursday, 8 April 2021 at 10.00am BST.
Final results for the year ended 31 December 2020
The Company is pleased to announce its audited results for the year ended 31 December 2020.